{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Cheung JW"],"funding":["Michael Wolk Heart Foundation","NCATS NIH HHS","Clinical and Translational Science Center at Weill Cornell Medicine","New York Cardiac Center, Inc.,","NIH","New York Weill Cornell Medical Center Alumni Council"],"pagination":["3035-3043"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7963138"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["40(36)"],"pubmed_abstract":["<h4>Aims</h4>Although catheter ablation has emerged as an important therapy for patients with symptomatic atrial fibrillation (AF), there are limited data on sex-based differences in outcomes. We sought to compare in-hospital outcomes and 30-day readmissions of women and men undergoing AF ablation.<h4>Methods and results</h4>Using the United States Nationwide Readmissions Database, we analysed patients undergoing AF ablation between 2010 and 2014. Based on ICD-9-CM codes, we identified co-morbidities and outcomes. Multivariable logistic regression and inverse probability-weighting analysis were performed to assess female sex as a predictor of endpoints. Of 54 597 study patients, 20 623 (37.7%) were female. After adjustment for age, co-morbidities, and hospital factors, women had higher rat"],"journal":["European heart journal"],"pubmed_title":["Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14."],"pmcid":["PMC7963138"],"funding_grant_id":["UL1 TR002384"],"pubmed_authors":["Cheung JW","Markowitz SM","Kim LK","Liu CF","Lerman BB","Yeo I","Thomas G","Christos PJ","Ip JE","Kamel H","Cheng EP","Wu X"],"additional_accession":[]},"is_claimable":false,"name":"Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14.","description":"<h4>Aims</h4>Although catheter ablation has emerged as an important therapy for patients with symptomatic atrial fibrillation (AF), there are limited data on sex-based differences in outcomes. We sought to compare in-hospital outcomes and 30-day readmissions of women and men undergoing AF ablation.<h4>Methods and results</h4>Using the United States Nationwide Readmissions Database, we analysed patients undergoing AF ablation between 2010 and 2014. Based on ICD-9-CM codes, we identified co-morbidities and outcomes. Multivariable logistic regression and inverse probability-weighting analysis were performed to assess female sex as a predictor of endpoints. Of 54 597 study patients, 20 623 (37.7%) were female. After adjustment for age, co-morbidities, and hospital factors, women had higher rat","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Sep","modification":"2025-04-26T00:47:50.792Z","creation":"2025-04-06T09:48:45.644Z"},"accession":"S-EPMC7963138","cross_references":{"pubmed":["30927423"],"doi":["10.1093/eurheartj/ehz151"]}}